Literature DB >> 12083367

Diazoxide protects the rabbit heart following cardioplegic ischemia.

Jun Feng1, Hongling Li, Eliot R Rosenkranz.   

Abstract

K(ATP) channels are present in sarcolemmal and mitochondrial membranes. This study tests the hypothesis that opening mitochondrial K(ATP) channels with Diazoxide (DZ) improves tolerance to cardioplegic ischemia during surgery. Twenty-two rabbit hearts were perfused with Krebs-Henseleit buffer (KHB) on a Langendorff apparatus and underwent 50 min of 37 degrees C global ischemia with St Thomas' cardioplegia (STCP). Hearts were divided into three groups. Ten (control) received no pretreatment. Seven (DZ) received 10 min of 30 microM DZ, a selective mitochondrial K(ATP) opener, in KHB before arrest with STCP containing 30 microM DZ. Five (5-HD + DZ) received 10 min of 100 microM sodium 5-hydroxydecanoate (5-HD), a selective mitochondrial K(ATP) channel blocker, followed by 10 min of 30 microM DZ and 100 microM 5-HD in KHB before arrest with STCP + 30 microM DZ + 100 microM 5-HD. LV developed pressure (LVDP), dP/dt and coronary flow (CF) were measured after 60 min of reperfusion. Diazoxide pretreatment significantly improved the recovery of LV function and coronary flow compared to control (LVDP: 49 +/- 5* vs. 31 +/- 4; +dP/dtmax 927 +/- 93 vs. 507 +/- 85 mmHg/sec*; CF 33 +/- 4 vs. 22 +/- 2 ml/min, *p < 0.05). Mitochondria K(ATP) channel blockade with 5-HD prevented DZ's salutary effect on the recovery of LV and vascular function. Diazoxide pretreatment protects the rabbit heart during cardioplegic ischemia by opening mitochondrial K(ATP) channels. Opening mitochondrial K(ATP) channels may be a new strategy for improving myocardial protection during cardiac surgery.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12083367     DOI: 10.1023/a:1015554211010

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  30 in total

1.  Pharmacologic characterization of BMS-191095, a mitochondrial K(ATP) opener with no peripheral vasodilator or cardiac action potential shortening activity.

Authors:  G J Grover; A J D'Alonzo; K D Garlid; R Bajgar; N J Lodge; P G Sleph; R B Darbenzio; T A Hess; M A Smith; P Paucek; K S Atwal
Journal:  J Pharmacol Exp Ther       Date:  2001-06       Impact factor: 4.030

2.  ATP-regulated K+ channels in cardiac muscle.

Authors:  A Noma
Journal:  Nature       Date:  1983 Sep 8-14       Impact factor: 49.962

3.  Opening of mitochondrial K(ATP) channels triggers the preconditioned state by generating free radicals.

Authors:  T Pain; X M Yang; S D Critz; Y Yue; A Nakano; G S Liu; G Heusch; M V Cohen; J M Downey
Journal:  Circ Res       Date:  2000-09-15       Impact factor: 17.367

4.  Cardioprotective effect of diazoxide and its interaction with mitochondrial ATP-sensitive K+ channels. Possible mechanism of cardioprotection.

Authors:  K D Garlid; P Paucek; V Yarov-Yarovoy; H N Murray; R B Darbenzio; A J D'Alonzo; N J Lodge; M A Smith; G J Grover
Journal:  Circ Res       Date:  1997-12       Impact factor: 17.367

5.  Limitation of myocardial infarct size in the rabbit by ischaemic preconditioning is abolished by sodium 5-hydroxydecanoate.

Authors:  E J Hide; C Thiemermann
Journal:  Cardiovasc Res       Date:  1996-06       Impact factor: 10.787

6.  Elective cardiac arrest with a hyperpolarizing adenosine triphosphate-sensitive potassium channel opener. A novel form of myocardial protection?

Authors:  N M Cohen; R M Wise; A S Wechsler; R J Damiano
Journal:  J Thorac Cardiovasc Surg       Date:  1993-08       Impact factor: 5.209

7.  Effects of potassium channel modulation during global ischaemia in isolated rat heart with and without cardioplegia.

Authors:  M Galiñanes; M J Shattock; D J Hearse
Journal:  Cardiovasc Res       Date:  1992-11       Impact factor: 10.787

8.  Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs.

Authors:  G J Gross; J A Auchampach
Journal:  Circ Res       Date:  1992-02       Impact factor: 17.367

9.  Cardioprotection with the KATP opener cromakalim is not correlated with ischemic myocardial action potential duration.

Authors:  G J Grover; A J D'Alonzo; C S Parham; R B Darbenzio
Journal:  J Cardiovasc Pharmacol       Date:  1995-07       Impact factor: 3.105

10.  The risk of myocardial stunning is decreased concentration-dependently by KATP channel activation with nicorandil before high K+ cardioplegia.

Authors:  S Sugimoto; K Iwashiro; F Monti; A A Dawodu; M Schiariti; P E Puddu
Journal:  Int J Cardiol       Date:  1995-01-27       Impact factor: 4.164

View more
  2 in total

Review 1.  Multiplicity of effectors of the cardioprotective agent, diazoxide.

Authors:  William A Coetzee
Journal:  Pharmacol Ther       Date:  2013-06-19       Impact factor: 12.310

2.  Diazoxide protects against doxorubicin-induced cardiotoxicity in the rat.

Authors:  Lisa Drange Hole; Terje Hjalmar Larsen; Kjell Ove Fossan; Fredrik Limé; Jan Schjøtt
Journal:  BMC Pharmacol Toxicol       Date:  2014-05-27       Impact factor: 2.483

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.